End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12,090 KRW | 0.00% |
|
+20.66% | +33.59% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Product Sales (ODM)
64.8
%
| - | - | 210 | 64.8 % | - |
Product Sales (General)
19.1
%
| - | - | 62 | 19.1 % | - |
Reagent
16.2
%
| 48 | 100.0 % | 52 | 16.2 % | +8.19% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 48 | 100.0 % | 324 | 100.0 % | +569.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Su-Jin Lee
FOU | Founder | 55 | 09-07-23 |
Sung-Hwan Moon
PSD | President | 65 | - |
Jun-Hee Jung
DFI | Director of Finance/CFO | 54 | - |
Jung-Ho Park
AUD | Comptroller/Controller/Auditor | 54 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Su-Jin Lee
FOU | Founder | 55 | 09-07-23 |
Jong-Nam Suh
BRD | Director/Board Member | 62 | - |
Sung-Hwan Moon
PSD | President | 65 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 22,298,866 | 14,131,436 ( 63.37 %) | 0 | 63.37 % |
Stock B | 0 | 1,037,574 | 0 | 0 |
Company contact information
![address AptaBio Therapeutics Inc.(A293780)](https://cdn.zonebourse.com/static/address/120975747.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+33.59% | 195M | |
+18.43% | 122B | |
+19.81% | 112B | |
-23.74% | 19.33B | |
-18.45% | 16.17B | |
-19.97% | 15.6B | |
-49.33% | 14.65B | |
+57.08% | 14.34B | |
+7.95% | 14B | |
+126.04% | 11.29B |
- Stock Market
- Equities
- A293780 Stock
- Company AptaBio Therapeutics Inc.